A detailed history of Cibc Private Wealth Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 201 shares of INCY stock, worth $14,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201
Previous 204 1.47%
Holding current value
$14,415
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $171 - $205
-3 Reduced 1.47%
201 $13,000
Q2 2024

Aug 09, 2024

BUY
$51.18 - $63.75 $3,224 - $4,016
63 Added 44.68%
204 $12,000
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $7,973 - $9,389
141 New
141 $8,000
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $990 - $1,195
15 New
15 $1,000
Q2 2018

Aug 02, 2018

SELL
$60.85 - $83.98 $17,281 - $23,850
-284 Closed
0 $0
Q1 2018

May 17, 2018

BUY
$83.06 - $100.98 $23,589 - $28,678
284 New
284 $24,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.